Procter & Gamble Company (The) $PG Shares Sold by Elite Life Management LLC

Elite Life Management LLC reduced its holdings in Procter & Gamble Company (The) (NYSE:PG) by 4.2% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,859 shares of the company’s stock after selling 82 shares during the quarter. Procter & Gamble accounts for 0.8% of Elite Life Management LLC’s portfolio, making the stock its 20th largest position. Elite Life Management LLC’s holdings in Procter & Gamble were worth $296,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently modified their holdings of PG. Kingstone Capital Partners Texas LLC raised its holdings in Procter & Gamble by 655,209.0% during the second quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company’s stock worth $11,832,680,000 after purchasing an additional 76,017,350 shares in the last quarter. Northern Trust Corp increased its position in shares of Procter & Gamble by 0.8% during the 1st quarter. Northern Trust Corp now owns 29,644,000 shares of the company’s stock valued at $5,051,930,000 after purchasing an additional 248,792 shares during the period. Price T Rowe Associates Inc. MD raised its stake in shares of Procter & Gamble by 13.0% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company’s stock worth $3,660,737,000 after buying an additional 2,466,308 shares in the last quarter. Goldman Sachs Group Inc. lifted its holdings in shares of Procter & Gamble by 3.5% in the first quarter. Goldman Sachs Group Inc. now owns 17,405,539 shares of the company’s stock valued at $2,966,252,000 after buying an additional 583,629 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in Procter & Gamble by 6.3% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 17,293,428 shares of the company’s stock valued at $2,947,146,000 after buying an additional 1,018,865 shares in the last quarter. Institutional investors own 65.77% of the company’s stock.

Procter & Gamble Stock Performance

Shares of Procter & Gamble stock opened at $149.56 on Friday. The business has a fifty day simple moving average of $154.04 and a 200-day simple moving average of $158.03. The stock has a market cap of $349.47 billion, a PE ratio of 21.83, a price-to-earnings-growth ratio of 3.87 and a beta of 0.36. The company has a quick ratio of 0.51, a current ratio of 0.71 and a debt-to-equity ratio of 0.46. Procter & Gamble Company has a 12 month low of $146.96 and a 12 month high of $180.43.

Procter & Gamble (NYSE:PG) last posted its earnings results on Friday, October 24th. The company reported $1.99 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.90 by $0.09. Procter & Gamble had a net margin of 19.74% and a return on equity of 32.63%. The business had revenue of $22.39 billion for the quarter, compared to analyst estimates of $22.23 billion. During the same period last year, the business posted $1.93 EPS. Procter & Gamble’s revenue was up 3.0% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.100 EPS. On average, sell-side analysts anticipate that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.

Procter & Gamble Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, November 17th. Stockholders of record on Friday, October 24th will be given a dividend of $1.0568 per share. The ex-dividend date is Friday, October 24th. This represents a $4.23 annualized dividend and a dividend yield of 2.8%. Procter & Gamble’s payout ratio is currently 61.75%.

Insider Buying and Selling at Procter & Gamble

In related news, insider Balaji Purushothaman sold 490 shares of the company’s stock in a transaction dated Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total transaction of $74,592.70. Following the sale, the insider owned 12,616 shares in the company, valued at approximately $1,920,533.68. This represents a 3.74% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CFO Andre Schulten sold 4,252 shares of Procter & Gamble stock in a transaction dated Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total value of $647,281.96. Following the transaction, the chief financial officer owned 53,992 shares of the company’s stock, valued at $8,219,202.16. The trade was a 7.30% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 150,488 shares of company stock valued at $23,529,718 over the last 90 days. Company insiders own 0.20% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have commented on the stock. BNP Paribas Exane dropped their price target on shares of Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating on the stock in a research report on Tuesday, September 23rd. Berenberg Bank lifted their price objective on shares of Procter & Gamble from $152.00 to $154.00 and gave the stock a “hold” rating in a research note on Wednesday, September 17th. JPMorgan Chase & Co. boosted their target price on shares of Procter & Gamble from $163.00 to $165.00 and gave the stock a “neutral” rating in a report on Monday. Barclays decreased their price target on shares of Procter & Gamble from $164.00 to $153.00 and set an “equal weight” rating on the stock in a research report on Wednesday, October 1st. Finally, Wells Fargo & Company cut their price objective on Procter & Gamble from $173.00 to $170.00 and set an “overweight” rating for the company in a research report on Thursday, September 25th. Twelve investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $171.53.

Procter & Gamble Profile

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.